What is the recommended dosage of acyclovir for treating cold sores?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acyclovir Dosing for Cold Sores (Herpes Labialis)

For cold sores, acyclovir 400 mg three times daily for 5 days is the recommended regimen, not 7 days. 1, 2

Correct Dosing Regimens

The CDC provides three equally effective options for treating recurrent oral herpes outbreaks, all for 5 days duration 1, 2:

  • Acyclovir 400 mg orally 3 times daily for 5 days 1, 2
  • Acyclovir 200 mg orally 5 times daily for 5 days 1, 2
  • Acyclovir 800 mg orally 2 times daily for 5 days 1, 2

The 400 mg three times daily regimen you mentioned is correct in dosage and frequency, but the duration should be 5 days, not 7 days. 1, 2

Timing of Treatment Initiation

Treatment must be initiated during the prodrome or within 2 days of lesion onset for maximum benefit. 1, 2 Starting therapy after this window significantly reduces effectiveness, and most immunocompetent patients with recurrent disease experience limited benefit from delayed therapy. 1, 2

Alternative Regimens with Superior Convenience

For patients seeking more convenient dosing schedules 2:

  • Acyclovir 800 mg twice daily for 5 days offers improved adherence while maintaining equivalent efficacy, demonstrating shorter symptom duration (8.1 vs 12.5 days with placebo, p=0.02) and reduced pain duration (2.5 vs 3.9 days with placebo, p=0.02) 2
  • Valacyclovir 2 g twice daily for 1 day provides comparable efficacy with superior convenience, reducing episode duration by 1.0 day (p=0.001) compared to placebo 2, 3

Critical Caveats

Oral acyclovir is significantly more effective than topical formulations and should always be preferred. 2 Topical acyclovir is substantially less effective than systemic therapy and its use is discouraged. 1

Patients must understand that acyclovir neither eradicates latent virus nor affects subsequent risk, frequency, or severity of recurrences after discontinuation. 1, 2 The medication treats the current outbreak but does not prevent future episodes.

Patients should abstain from activities that might spread the virus while lesions are present, though transmission can occur during asymptomatic periods. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Recommended Loading Dose of Acyclovir for Oral Herpes Outbreak

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.